Safer and more broadly effective rotavirus vaccines could be achieved if initial investigations 1 into the boosting effect of plant-derived virus-like particles hold up in further trials.

Results of two multinational, randomized, double-blind, placebo-controlled trials that together enrolled 131,263 children have confirmed the safety and efficacy of two new oral rotavirus vaccines.